Clinical Trial of Clinical Efficiency and Safety of Ergoferon in Treatment of Influenza

PHASE4CompletedINTERVENTIONAL
Enrollment

161

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

April 30, 2014

Study Completion Date

October 31, 2014

Conditions
Influenza
Interventions
DRUG

Ergoferon

Safety and Efficiency of Ergoferon in treatment of Influenza

DRUG

Oseltamivir

Safety and Efficiency in treatment of Influenza

Trial Locations (8)

105064

"Federal State Budgetary Institution Scientific Research Institute for Vaccines and Serum named after I.I.Mechnikov of Russian Academy of Medical Science", Moscow

117997

"State Budgetary Educational Institution of Higher Professional Education The Russian National Research Medical University named after N.I. Pirogov of Ministry of Health and Social Development of Russian Federation", Moscow

129090

"Federal State Budgetary Institution Polyclinic № 3 of Affairs Management Department of the President of Russian Federation", Moscow

150000

"State Budgetary Educational Institution of Higher Professional Education Yaroslavl State Medical Academy of Ministry of Health and Social Development of Russian Federation", Yaroslavl

198328

"St. Petersburg State Budgetary Health Care Institution City Polyclinic №106", Saint Petersburg

214019

"State Budgetary Educational Institution of Higher Professional Education Smolensk State Medical Academy of Ministry of Health and Social Development of Russian Federation", Smolensk

394036

"State Educational Institution of Higher Professional Education Voronezh State Academy named after N.N. Burdenko of Ministry of Health and Social Development of Russian Federation", Voronezh

Unknown

"St. Petersburg State Budgetary Health Care Institution Сity Polyclinic № 117", Saint Petersburg

Sponsors
All Listed Sponsors
lead

Materia Medica Holding

INDUSTRY

NCT01804946 - Clinical Trial of Clinical Efficiency and Safety of Ergoferon in Treatment of Influenza | Biotech Hunter | Biotech Hunter